Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | ALPL | P05186 | 1/20 | 0.30 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.30 |
| ▸ | ALPI | P09923 | 1/20 | 0.30 |
| ▸ | ALPG | P10696 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | CCR1 | P32246 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12081976 | 0.74 | DAPK3 (0.32) | SMN1; SMN2GAA | |
| SCHEMBL439225 | 0.68 | KDM4E (0.49) | ALDH1A1MAPTHSD17B10MEN1RAB9A | |
| SCHEMBL2249334 | 0.67 | CYP11B2 (0.34) | ALDH1A1MAPTHPGDHSD17B10MEN1 | |
| SCHEMBL7567155 | 0.67 | — | — | |
| SCHEMBL4901096 | 0.67 | ACHE (0.39) | ALDH1A1HPGDHSD17B10RAB9ASMN1; SMN2 | |
| SCHEMBL6443245 | 0.63 | — | — | |
| SCHEMBL20981454 | 0.63 | — | — | |
| SCHEMBL13317702 | 0.63 | — | — | |
| SCHEMBL8444359 | 0.60 | — | — | |
| SCHEMBL536875 | 0.58 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240288410-A1 | SELECTIVE OPTICAL AQUEOUS AND NONAQUEOUS DETECTION OF FREE SULFITES | UNIV NEW YORK STATE RES FOUND (US) | 2024-08-29 | — | — | US | disclosed |
| US-11953479-B2 | Selective optical aqueous and non-aqueous detection of free sulfites | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2024-04-09 | — | — | US | disclosed |
| EP-3692366-B1 | SELECTIVE OPTICAL AQUEOUS AND NON-AQUEOUS DETECTION OF FREE SULFITES | UNIV NEW YORK STATE RES FOUND (US) | 2022-12-14 | — | — | EP | disclosed |
| US-20200363382-A1 | SELECTIVE OPTICAL AQUEOUS AND NONAQUEOUS DETECTION OF FREE SULFITES | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY FOR THE STATE OF NEW YORK | 2020-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240288410-A1 | SELECTIVE OPTICAL AQUEOUS AND NONAQUEOUS DETECTION OF FREE SULFITES | PRDX4, PTPN12, PTPN4 | ALDH1A1 2308/4885POLB 1866/4885MAPT 4554/4885 |
| US-20200363382-A1 | SELECTIVE OPTICAL AQUEOUS AND NONAQUEOUS DETECTION OF FREE SULFITES | PRDX4, PTPN12, PTPN4 | ALDH1A1 2280/4885POLB 1828/4885MAPT 4540/4885 |
| US-11953479-B2 | Selective optical aqueous and non-aqueous detection of free sulfites | PTPN4, PTPN12, PRDX4 | ALDH1A1 2128/4885POLB 1737/4885MAPT 4426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.